Chartsonlygoup's future update (it'll live): tomwong.xyz/stock-status/

What is AMGN's Gross Profit Margin Ratio?

  Amgen Inc ( AMGN ) |
1989 - 2021 (33 years)

Gross Profit Margin Ratio is 
3.03 (1Y -3.27% )

AMGN Stock Price & Gross Profit Margin Ratio

Gross Profit Margin Ratio for AMGN competitors.
ALXN CELG GILD BIIB GSK BMY JNJ PFE ABBV
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Gross Profit Margin Ratio

chevron_right 2021 0.76 -0.7x
( -3.9% / year avg)
chevron_left 1989 2.82
vertical_align_top Peak 4.64 +5.11x
vertical_align_bottom Bottom 0.76
arrow_drop_up # Up Years 16 16 of 33
years up.
arrow_drop_down # Down Years 17
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • AMGN's stock price has rallied +113,400% from $0.22 in 1989 , or -1618.6x faster than it's gross profit margin ratio over the same period.
  • If AMGN shrinks it's stock at the same rate as it's gross profit margin ratio (-3.9%/year) , it's stock price will shrink +67.2% and hit $165.76 over the next 10 years.
  • AMGN's stock price has gone up 0 of the 16 years (0%) it's gross profit margin ratio were also up.
  • AMGN Historical Gross Profit Margin Ratio Table

    Year Gross Profit Margin Ratio YoY % Change Stock Price YoY % Change (Stock Price)
    4/1/2021 0.76 -75.3% - -
    4/1/2020 3.07 -6.5% - -
    4/1/2019 3.28 -0.7% - -
    4/1/2018 3.3 0.4% - -
    4/1/2017 3.29 0.9% - -
    4/1/2016 3.26 2.2% - -
    4/1/2015 3.19 1.8% - -
    4/1/2014 3.13 -5.0% - -
    4/1/2013 3.3 -1.6% - -
    4/1/2012 3.35 -1.2% - -
    4/1/2011 3.39 -0.7% - -
    4/1/2010 3.42 -0.1% - -
    4/1/2009 3.42 1.3% - -
    4/1/2008 3.38 1.5% - -
    4/1/2007 3.32 -2.2% - -
    4/1/2006 3.4 2.4% - -
    4/1/2005 3.32 -0.6% - -
    4/1/2004 3.34 -0.8% - -
    4/1/2003 3.37 -3.7% - -
    4/1/2002 3.5 -3.8% - -
    4/1/2001 3.64 28.3% - -
    4/1/2000 2.84 -38.9% - -
    4/1/1999 4.64 26.0% - -
    4/1/1998 3.68 -0.2% - -
    4/1/1997 3.69 0.5% - -
    4/1/1996 3.67 2.1% - -
    4/1/1995 3.6 33.6% - -
    4/1/1994 2.69 2.6% - -
    4/1/1993 2.63 1.0% - -
    4/1/1992 2.6 51.5% - -
    4/1/1991 1.72 -31.9% - -
    4/1/1990 2.52 -10.5% - -
    4/1/1989 2.82 - - -

  • About
    Industry: Drug Manufacturers General
    Sector: Healthcare
    Country: US
    IPO Date: 5/1/1987
    Stonk Exchange: NASDAQ
    • Amgen, Inc
    • is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics.
    • The company is headquartered in Thousand Oaks, California and currently employs 21,500 full-time employees.
    • The firm discovers, develops, manufactures and delivers various human therapeutics.
    • The company operates in human therapeutics segment.
    • Its marketed products portfolio includes Neulasta (pegfilgrastim); erythropoiesis-stimulating agents (ESAs), such as Aranesp (darbepoetin alfa) and EPOGEN (epoetin alfa); Sensipar/Mimpara (cinacalcet); XGEVA (denosumab); Prolia (denosumab); NEUPOGEN (filgrastim), and other marketed products, such as KYPROLIS (carfilzomib), Vectibix (panitumumab), Nplate (romiplostim), Repatha (evolocumab), BLINCYTO (blinatumomab), IMLYGIC (talimogene laherparepvec) and Corlanor (ivabradine).
    • The company focuses on human therapeutics for the treatment of serious illness in the areas of oncology/hematology, cardiovascular disease and neuroscience.
    • Its product candidates in Phase III include Erenumab for episodic migraine, Aranesp for myelodysplastic syndromes, BLINCYTO for acute lymphoblastic leukemia and IMLYGIC for metastatic melanoma.

  • Gross profit margin is a profitability ratio that calculates the percentage of sales that exceed the cost of goods sold. In other words, it measures how efficiently a company uses its materials and labor to produce and sell products profitably. You can think of it as the amount of money from product sales left over after all of the direct costs associated with manufacturing the product have been paid. These direct costs are typically called cost of goods sold or COGS and usually consist of raw materials and direct labor.

    For more detailed definitions, please see Investopedia.